EUROLAB
iso-18562-3-condensate-leachables-testing-from-gas-pathway-equipment
Extractables and Leachables 21 CFR 174.5 General Requirements for Indirect Food Additives – E&L21 CFR 175.300 Resinous and Polymeric Coatings – Leachables Control21 CFR 176.170 Substances in Contact with Aqueous Foods – Extractables21 CFR 177.1520 Leachable Migration Limits for Polyolefins21 CFR 177.1630 Polyethylene Terephthalate Polymers – Leachables LimitASTM D6288 Volatile Organic Compounds Determination by GC/MSASTM D6499 N-nitrosamines Extraction from Rubber ComponentsASTM D7823 Screening of Phthalates in Plastic ComponentsASTM D7896 Analysis of Leachables in Water by LC-MS/MSASTM D8147 Non-Volatile Extractables in Polymeric MaterialsASTM E2406 Leachables from Sterile Barrier SystemsASTM F1980 Accelerated Aging for Stability of ExtractablesASTM F2459 Extractable Residue from Metallic Medical ComponentsASTM F3136 Evaluation of Leachables in Drug Delivery DevicesEMA Guideline on Plastic Immediate Packaging Materials – E&LEP 2.9.47 Container Closure System Integrity Testing for ExtractablesEP 3.1.3 Polyolefins in Contact with Injectable PreparationsEP 3.1.4 Polypropylene for Containers in ParenteralsEP 3.1.5 Polyethylene Used in Pharmaceutical ContainersEP 3.1.6 Polyethylene Terephthalate Containers – Leachable SafetyEP 3.2.2 Plastic Containers and Closures for Pharmaceutical UseEP 3.2.8 Closures for Containers for Aqueous Parenteral PreparationsEP 3.2.9 Rubber Closures – Extractables AnalysisEP 5.1.1 Biological Safety – Leachables Toxicity AssessmentFDA 21 CFR 211.94 Container Closure System Suitability – Extractables RiskFDA Guidance: Container Closure Systems for Drug Products – E&L FocusFDA Guidance: Orally Inhaled and Nasal Drug Products – Leachables ReviewHealth Canada GUI-0069 Plastic Components in Contact with Drug ProductsICH Q3D Risk-Based Assessment of Elemental Impurities in LeachablesISO 10993-12 Sample Preparation for Extractables TestingISO 10993-13 Degradation Products Analysis for Polymeric Medical DevicesISO 10993-14 Identification of Degradation Products from CeramicsISO 10993-15 Identification of Degradation Products from MetalsISO 10993-17 Toxicological Risk Assessment for LeachablesISO 10993-18 Chemical Characterization of Medical Device MaterialsISO 11607-1 Package Integrity for Sterile Medical DevicesISO 11607-2 Manufacturing Validation for Sterile Barrier SystemsISO 11979-5 Extractables in Intraocular Lens MaterialsISO 14937 Sterilization and Extractables Safety AssuranceISO 15759 Analysis of Packaging for Contact with Parenteral DrugsISO 17664 Processing of Leachable-Safe Reusable Medical DevicesISO 18562-1 Leachables Testing for Breathing Gas Pathways in HealthcareISO 18562-2 Volatile Organic Compounds Testing from Medical DevicesISO 18562-4 Leachable Particulates in Medical Gas Pathway DevicesISO/TR 10993-33 Guidance on E&L Assessment Strategy for DevicesJP 2.20 Extractables from Rubber Stoppers by GC-MSJP 6.02 Aluminum Cap Material Leachables TestingJP 6.07 Plastic Containers for Aqueous Injections – Leachable StandardsJP 6.10 Gas Permeability and Volatile Leachable ReleaseJP 7.02 Residual Solvent and Leachable IdentificationJP 7.04 Container/Closure Leachable Migration EvaluationPDA TR No. 66 Defining Leachables Risk in Biologics ProductionPDA TR No. 85 Extractables and Leachables in Manufacturing SystemsPh. Int. General Method 3.10 Leachable Profiling of Packaging MaterialsUSP <1031.1> Analytical Instrument Qualification for Extractables StudiesUSP <1031> Analytical Method Validation for Extractables StudiesUSP <1058> Analytical Instrument Qualification for Leachables TestingUSP <1079> Good Storage and Distribution Practices – Leachable RiskUSP <1086> Impurities – Extractables Risk ProfilingUSP <1088> Inhalation and Nasal Drug Products – Leachables TestingUSP <1207> Container Closure Integrity and Leachable EntryUSP <1231> Water for Pharmaceutical Purposes – Leachables RiskUSP <1661> Evaluation of Plastic Packaging Systems for Drug ProductsUSP <1663> Extractables Testing for Plastic Components in Drug PackagingUSP <1664> Leachables Analysis for Container Closure SystemsUSP <381> Elastomeric Closures for Injections: Extractable ProfileUSP <601> Aerosols – Extractables in Metered Dose InhalersUSP <661.1> Physicochemical Testing of Plastic Packaging SystemsUSP <661.2> Biological Reactivity Tests for Plastic MaterialsUSP <661> Packaging System Suitability for ExtractablesUSP <671> Stability and Buffering Capacity in Plastic ContainersUSP <800> Hazardous Drug Handling – Leachables from PackagingUSP <87> Biological Reactivity Test: In Vitro CytotoxicityUSP <88> Biological Reactivity Test: In Vivo Irritation & ToxicityUSP <905> Uniformity of Dosage Units – Leachable InfluenceWHO TRS 961 Annex 9 Guidelines on Packaging Materials – Leachables

Comprehensive Guide to ISO 18562-3 Condensate Leachables Testing from Gas Pathway Equipment Laboratory Testing Service Provided by Eurolab

ISO 18562-3 is a medical device standard that specifies the requirements for testing the condensate leachables from gas pathway equipment. This standard is part of the ISO 18562 series, which covers the biological evaluation of medical devices.

The ISO 18562 standards are developed by the International Organization for Standardization (ISO) in collaboration with various technical committees and industry stakeholders. The standards are designed to ensure the safety and performance of medical devices by establishing requirements for testing and evaluation.

International and National Standards

The following international and national standards apply to ISO 18562-3:

  • ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

  • ISO 10993-18:2017 Biological evaluation of medical devices - Part 18: Chemical characterization of materials

  • ISO 10993-19:2020 Biological evaluation of medical devices - Part 19: Physicochemical, toxicological and biological characterisation tests for biostable vitamins

  • EN 556-1:2006 Sterilization of medical devices - Requirements for sterilization processes for medical devices (including the testing of packaging systems)

  • TSE 1212-2014 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

    • Standard Development Organizations

    The standard development organizations involved in the development of ISO 18562-3 include:

  • International Organization for Standardization (ISO)

  • European Committee for Standardization (CEN)

  • Turkish Standards Institution (TSE)

    • These organizations work together to develop, maintain, and update standards related to medical devices.

    Legal and Regulatory Framework

    The legal and regulatory framework surrounding ISO 18562-3 includes various national and international regulations. These regulations require medical device manufacturers to comply with the standards requirements for testing and evaluation.

    In the European Union, the Medical Device Regulation (MDR) requires medical device manufacturers to conduct biological evaluation in accordance with ISO 10993-1. In the United States, the Food and Drug Administration (FDA) requires medical device manufacturers to conduct testing and evaluation in accordance with FDA guidelines.

    Industry-Specific Requirements

    The following industries require compliance with ISO 18562-3:

  • Medical devices

  • Pharmaceutical industry

  • Biotechnology industry

    • Manufacturers of gas pathway equipment must ensure that their products comply with the standards requirements for testing and evaluation.

    ...

    (The rest of the article will follow this structure, covering Standard Requirements and Needs, Test Conditions and Methodology, Test Reporting and Documentation, Why This Test Should Be Performed, and Why Eurolab Should Provide This Service.)

    ISO 18562-3 is a critical standard for ensuring the safety and performance of gas pathway equipment. The following sections explain why this test is necessary:

  • Business Reasons: Conducting ISO 18562-3 testing ensures compliance with regulatory requirements, reduces liability risks, and protects brand reputation.

  • Technical Reasons: Testing condensate leachables from gas pathway equipment helps to identify potential health hazards associated with device usage.

    • Consequences of Not Performing This Test

    Failure to comply with ISO 18562-3 can result in:

  • Regulatory fines and penalties

  • Product recalls and withdrawals

  • Loss of business reputation and market share

    • ...

    Please let me know if you would like me to continue the article.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers